Home/Publication/Bayland, GTJA & Proxima in Drug Discovery Platform
Bayland, GTJA & Proxima in Drug Discovery Platform 

21 Oct 2025

US$ 20.00

Bayland Capital, an affiliate of Legend Capital, has led the US$28 m series B+ funding round of US-headquartered ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 24 Oct 2025...

Listen to Australia/New Zealand News (Subscribers' Weekly 24 Oct 2025)...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.